Followers | 3350 |
Posts | 84724 |
Boards Moderated | 6 |
Alias Born | 10/05/2005 |
Friday, August 25, 2023 12:27:33 AM
Recent YS News
- YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer • PR Newswire (US) • 05/07/2024 08:20:00 PM
- YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule • PR Newswire (US) • 04/29/2024 12:00:00 PM
- YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 • PR Newswire (US) • 04/19/2024 11:00:00 AM
- YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine • PR Newswire (US) • 04/18/2024 12:00:00 PM
- YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024 • PR Newswire (US) • 04/16/2024 12:00:00 PM
- YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine • PR Newswire (US) • 04/09/2024 12:00:00 PM
- YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility • PR Newswire (US) • 04/03/2024 12:00:00 PM
- YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries • PR Newswire (US) • 03/05/2024 01:00:00 PM
- YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024 • PR Newswire (US) • 02/22/2024 10:00:00 PM
- /C O R R E C T I O N -- YS Biopharma Co., Ltd./ • PR Newswire (US) • 02/18/2024 09:30:00 AM
- YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting • PR Newswire (US) • 02/17/2024 01:20:00 AM
- YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance • PR Newswire (US) • 02/14/2024 01:00:00 PM
- YS Biopharma Announces Appointment of New Directors • PR Newswire (US) • 02/14/2024 12:50:00 PM
- YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd. • PR Newswire (US) • 02/12/2024 01:50:00 PM
- YS Biopharma Announces US$40 Million Private Placement Financing • PR Newswire (US) • 02/09/2024 11:30:00 AM
- Shareholders of YS Biopharma Announce an Extraordinary General Meeting • PR Newswire (US) • 02/08/2024 11:10:00 PM
- YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024 • PR Newswire (US) • 01/22/2024 10:00:00 PM
- YS Biopharma Announces Changes to its Board Committees • PR Newswire (US) • 01/08/2024 01:00:00 PM
- YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting • PR Newswire (US) • 12/20/2023 09:30:00 PM
- YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023 • PR Newswire (US) • 12/20/2023 01:56:00 PM
- Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target • PR Newswire (US) • 11/14/2023 01:30:00 PM
- YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine • PR Newswire (US) • 10/31/2023 12:30:00 PM
- YS Biopharma Announces Receipt of Nasdaq Notice • PR Newswire (US) • 10/26/2023 12:30:00 PM
- YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine • PR Newswire (US) • 09/26/2023 12:30:00 PM
- YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection • PR Newswire (US) • 09/15/2023 12:30:00 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM